Gene Therapy Podcast with Hugh Davis

In this podcast, Hugh Davis, Chief Business Officer at Frontage Laboratories, discusses how bioanalytical laboratories like Frontage keep up with the latest therapies, challenges of a clinical development program design, bioanalytical considerations in developing assays, and the future of this field in the next 5-10 years.

Video thumbnail

Thank you for registering!

You may now view the resource below.